Comments
Loading...
Stime degli utili, EPS e fatturato
ACADIA Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 5
Stima EPS
$0.140
Stima dei ricavi trimestrali
$275.28M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$1.02B
Analizza lo storico degli utili di ACADIA Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ACAD | ACADIA Pharmaceuticals | $0.20 | $0.14 | — | — | $250.40M | $275.28M | — | — | 11/05/2025 | |
ACAD | ACADIA Pharmaceuticals | $0.20 | $0.14 | $0.16 | 14.29% | $241.96M | $261.14M | $264.57M | 1.31% | 08/06/2025 | |
ACAD | ACADIA Pharmaceuticals | $0.10 | -$0.03 | $0.11 | 466.67% | $205.83M | $239.34M | $244.32M | 2.08% | 05/07/2025 | |
ACAD | ACADIA Pharmaceuticals | $0.28 | $0.23 | $0.08 | -65.22% | $231.04M | $277.65M | $259.60M | -6.50% | 02/26/2025 | |
ACAD | ACADIA Pharmaceuticals | -$0.40 | $0.14 | $0.20 | 42.86% | $211.70M | $248.81M | $250.40M | 0.64% | 11/06/2024 | |
ACAD | ACADIA Pharmaceuticals | $0.01 | $0.19 | $0.20 | 5.26% | $165.24M | $236.00M | $241.96M | 2.53% | 08/06/2024 | |
ACAD | ACADIA Pharmaceuticals | -$0.27 | $0.05 | $0.10 | 100.00% | $118.46M | $208.36M | $205.83M | -1.21% | 05/08/2024 | |
ACAD | ACADIA Pharmaceuticals | -$0.26 | $0.30 | $0.28 | -6.67% | $136.49M | $223.70M | $231.04M | 3.28% | 02/27/2024 | |
ACAD | ACADIA Pharmaceuticals | -$0.17 | -$0.43 | -$0.40 | 6.98% | $130.71M | $189.51M | $211.70M | 11.71% | 11/02/2023 | |
ACAD | ACADIA Pharmaceuticals | -$0.21 | -$0.08 | $0.01 | 112.50% | $134.56M | $157.81M | $165.24M | 4.71% | 08/02/2023 | |
ACAD | ACADIA Pharmaceuticals | -$0.70 | -$0.21 | -$0.27 | -28.57% | $115.47M | $120.29M | $118.46M | -1.52% | 05/08/2023 | |
ACAD | ACADIA Pharmaceuticals | -$0.27 | -$0.24 | -$0.26 | -8.33% | $130.76M | $134.07M | $136.49M | 1.81% | 02/27/2023 | |
ACAD | ACADIA Pharmaceuticals | -$0.09 | -$0.18 | -$0.17 | 5.56% | $131.61M | $139.86M | $130.71M | -6.54% | 11/02/2022 | |
ACAD | ACADIA Pharmaceuticals | -$0.27 | -$0.25 | -$0.21 | 16.00% | $115.22M | $130.43M | $134.56M | 3.17% | 08/08/2022 | |
ACAD | ACADIA Pharmaceuticals | -$0.42 | -$0.60 | -$0.70 | -16.67% | $106.55M | $121.92M | $115.47M | -5.29% | 05/04/2022 | |
ACAD | ACADIA Pharmaceuticals | -$0.42 | -$0.24 | -$0.27 | -12.50% | $121.01M | $135.60M | $130.76M | -3.57% | 02/28/2022 | |
ACAD | ACADIA Pharmaceuticals | -$0.54 | -$0.26 | -$0.09 | 65.38% | $120.58M | $127.75M | $131.61M | 3.02% | 11/08/2021 | |
ACAD | ACADIA Pharmaceuticals | -$0.27 | -$0.31 | -$0.27 | 12.90% | $110.10M | $126.15M | $115.22M | -8.66% | 08/04/2021 | |
ACAD | ACADIA Pharmaceuticals | -$0.57 | -$0.53 | -$0.42 | 20.75% | $90.07M | $111.63M | $106.55M | -4.55% | 05/05/2021 | |
ACAD | ACADIA Pharmaceuticals | -$0.34 | -$0.47 | -$0.42 | 10.64% | $98.33M | $123.20M | $121.01M | -1.78% | 02/24/2021 | |
ACAD | ACADIA Pharmaceuticals | -$0.29 | -$0.38 | -$0.54 | -42.11% | $94.59M | $118.82M | $120.58M | 1.48% | 11/04/2020 |
ACADIA Pharmaceuticals (ACAD) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $0.16 | $0.14 | 14.3 % |
| Q1 | 2025-05-07 | $0.11 | $-0.03 | 466.7 % |
| Q4 | 2025-02-26 | $0.08 | $0.23 | -65.2 % |
| Q3 | 2024-11-06 | $0.20 | $0.14 | 42.9 % |
ACADIA Pharmaceuticals (ACAD) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $264.57M | $261.14M | 1.31 % |
| Q1 | 2025-05-07 | $244.32M | $239.34M | 2.08 % |
| Q4 | 2025-02-26 | $259.60M | $277.65M | -6.50 % |
| Q3 | 2024-11-06 | $250.40M | $248.81M | 0.64 % |
FAQ
Quando ACADIA Pharmaceuticals (NASDAQ:ACAD) riporterà gli utili?
Si prevede che ACADIA Pharmaceuticals (ACAD) fornisca risultati il novembre 5, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di ACADIA Pharmaceuticals (NASDAQ:ACAD)?
L'EPS effettivo era $0.16, che superato la stima di $0.14.
Quali sono state le entrate di ACADIA Pharmaceuticals (NASDAQ:ACAD)?
Le entrate effettive sono state $264.6M, che superato la stima di $261.1M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.